{
    "medicine_id": "33c8990f2b4f9f942c44cd6ee2af682485d43ec2",
    "platform_id": "DB06073",
    "metadata": {
        "name": "Lartruvo 10 mg 1mL Injection solution",
        "composition": "10 mg 1mL CTS 21166",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in alzheimer s disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "CTS 21166 produced a rapid and significant reduction of plasma amyloid beta a key biomarker that is believed to be involved in the pathogenesis of Alzheimer s disease CTS 21166 demonstrated excellent pharmacokinetic properties including dose proportional exposure and very low inter subject pharmacokinetic variability",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}